
- /
- Supported exchanges
- / US
- / AKYA.NASDAQ
Akoya Biosciences Inc (AKYA NASDAQ) stock market data APIs
Akoya Biosciences Inc Financial Data Overview
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Akoya Biosciences Inc data using free add-ons & libraries
Get Akoya Biosciences Inc Fundamental Data
Akoya Biosciences Inc Fundamental data includes:
- Net Revenue: 79 961 K
- EBITDA: -30 011 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.23
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Akoya Biosciences Inc News

Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BILLERICA, Mass., July 11, 2025--(BUSINESS WIRE)--Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detectio...


Quanterix completes acquisition of Akoya Biosciences, delisting set from Nasdaq
Quanterix Corporation (NASDAQ:QTRX) has completed its acquisition of Akoya Biosciences , Inc. (NASDAQ:AKYA), a company with a market capitalization of $64.4 million and annual revenue of approximate...

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Wall Street expects a year-over-year increase in earnings on higher revenues when Akoya Biosciences (AKYA) reports results for the quarter ended March 2025. While this widely-known consensus outlook i...

Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar?
Zealand Pharma A/S (ZLDPF) shares ended the last trading session 8% higher at $72.28. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. T...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.